CRBN expression was found to be significantly reduced in cancer tissues compared to normal tissues and was positively correlated with patient survival in multiple types of cancers including kidney renal clear cell carcinoma, lung adenocarcinoma, and skin cutaneous melanoma. Here, CRBN is linked to lung adenocarcinoma.